In vitro activities of semisynthetic pneumocandin L-733,560 against fluconazole-resistant and -susceptible Candida albicans isolates

被引:29
作者
MartinezSuarez, JV
RodriguezTudela, JL
机构
关键词
D O I
10.1128/AAC.40.5.1277
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Lipopeptide L-733,560 is a water-soluble derivative of pneumocandin B-0 that exhibits enhanced anti-Candida activity. We investigated the in vitro activity of L-733,560 compared with those of amphotericin B, flucytosine, and itraconazole, against fluconazole-resistant (n = 44) and fluconazole-susceptible (n = 46) Candida albicans isolates. Tests were performed with a photometer-read broth microdilution method with RPMI-2% glucose and National Committee for Clinical Laboratory Standards reference strains. Except for those of itraconazole, MICs were not significantly different between the two groups of isolates, as expected for agents with different mechanisms of action. L-733,560 was the most active agent against C. albicans, with MICs for 50 and 90% of the strains tested of 0.01 and 0.06 mu g/ml, respectively.
引用
收藏
页码:1277 / 1279
页数:3
相关论文
共 20 条
[1]   EVALUATION OF WATER-SOLUBLE PNEUMOCANDIN ANALOGS L-733560, L-705589, AND L-731373 WITH MOUSE MODELS OF DISSEMINATED ASPERGILLOSIS, CANDIDIASIS, AND CRYPTOCOCCOSIS [J].
ABRUZZO, GK ;
FLATTERY, AM ;
GILL, CJ ;
KONG, L ;
SMITH, JG ;
KRUPA, D ;
PIKOUNIS, VB ;
KROPP, H ;
BARTIZAL, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (05) :1077-1081
[2]   FLUCONAZOLE SUSCEPTIBILITY TESTING OF CANDIDA-ALBICANS - MICROTITER METHOD THAT IS INDEPENDENT OF INOCULUM SIZE, TEMPERATURE, AND TIME OF READING [J].
ANAISSIE, E ;
PAETZNICK, V ;
BODEY, GP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (08) :1641-1646
[3]   CORRELATION BETWEEN IN-VITRO AND IN-VIVO ACTIVITY OF ANTIFUNGAL AGENTS AGAINST CANDIDA SPECIES [J].
ANAISSIE, EJ ;
KARYOTAKIS, NC ;
HACHEM, R ;
DIGNANI, MC ;
REX, JH ;
PAETZNICK, V .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (02) :384-389
[4]   IN-VITRO ACTIVITY OF ITRACONAZOLE AGAINST FLUCONAZOLE-SUSCEPTIBLE AND FLUCONAZOLE-RESISTANT CANDIDA-ALBICANS ISOLATES FROM ORAL CAVITIES OF PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS [J].
BARCHIESI, F ;
COLOMBO, AL ;
MCGOUGH, DA ;
FOTHERGILL, AW ;
RINALDI, MG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (07) :1530-1533
[5]   IN-VITRO EVALUATION OF THE PNEUMOCANDIN ANTIFUNGAL AGENT L-733560, A NEW WATER-SOLUBLE HYBRID OF L-705589 AND L-731373 [J].
BARTIZAL, K ;
SCOTT, T ;
ABRUZZO, GK ;
GILL, CJ ;
PACHOLOK, C ;
LYNCH, L ;
KROPP, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (05) :1070-1076
[6]   ANTIBIOTICS THAT INHIBIT FUNGAL CELL-WALL DEVELOPMENT [J].
DEBONO, M ;
GORDEE, RS .
ANNUAL REVIEW OF MICROBIOLOGY, 1994, 48 :471-497
[7]  
Espinel-Ingroff Ana, 1995, P1405
[8]   COMPARISON OF 2 ALTERNATIVE MICRODILUTION PROCEDURES WITH THE NATIONAL-COMMITTEE-FOR-CLINICAL-LABORATORY-STANDARDS REFERENCE MACRODILUTION METHOD M27-P FOR IN-VITRO TESTING OF FLUCONAZOLE-RESISTANT AND FLUCONAZOLE-SUSCEPTIBLE ISOLATES OF CANDIDA-ALBICANS [J].
ESPINELINGROFF, A ;
RODRIGUEZTUDELA, JL ;
MARTINEZSUAREZ, JV .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (12) :3154-3158
[9]   INCREASED ANTIFUNGAL ACTIVITY OF L-733,560, A WATER-SOLUBLE, SEMISYNTHETIC PNEUMOCANDIN, IS DUE TO ENHANCED INHIBITION OF CELL-WALL SYNTHESIS [J].
KURTZ, MB ;
DOUGLAS, C ;
MARRINAN, J ;
NOLLSTADT, K ;
ONISHI, J ;
DREIKORN, S ;
MILLIGAN, J ;
MANDALA, S ;
THOMPSON, J ;
BALKOVEC, JM ;
BOUFFARD, FA ;
DROPINSKI, JF ;
HAMMOND, ML ;
ZAMBIAS, RA ;
ABRUZZO, G ;
BARTIZAL, K ;
MCMANUS, OB ;
GARCIA, ML .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (12) :2750-2757
[10]   AEROSOL AND PARENTERAL PNEUMOCANDINS ARE EFFECTIVE IN A RAT MODEL OF PULMONARY ASPERGILLOSIS [J].
KURTZ, MB ;
BERNARD, EM ;
EDWARDS, FF ;
MARRINAN, JA ;
DROPINSKI, J ;
DOUGLAS, CM ;
ARMSTRONG, D .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (08) :1784-1789